Literature DB >> 18522829

Hypertension and cerebrovascular dysfunction.

Costantino Iadecola1, Robin L Davisson.   

Abstract

Essential hypertension has devastating effects on the brain, being the major cause of stroke and a leading cause of dementia. Hypertension alters the structure of cerebral blood vessels and disrupts intricate vasoregulatory mechanisms that assure an adequate blood supply to the brain. These alterations threaten the cerebral blood supply and increase the susceptibility of the brain to ischemic injury as well as Alzheimer's disease. This review focuses on the mechanisms by which hypertension disrupts cerebral blood vessels, highlighting recent advances and outstanding issues.

Entities:  

Mesh:

Year:  2008        PMID: 18522829      PMCID: PMC2475602          DOI: 10.1016/j.cmet.2008.03.010

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  90 in total

Review 1.  Update on hypertension and Alzheimer's disease.

Authors:  Ingmar Skoog; Deborah Gustafson
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

Review 2.  Endothelial influences on cerebrovascular tone.

Authors:  Jon Andresen; Nadeem I Shafi; Robert M Bryan
Journal:  J Appl Physiol (1985)       Date:  2006-01

3.  Critical role for CuZn-superoxide dismutase in preventing angiotensin II-induced endothelial dysfunction.

Authors:  Sean P Didion; Dale A Kinzenbaw; Frank M Faraci
Journal:  Hypertension       Date:  2005-10-10       Impact factor: 10.190

Review 4.  Endothelial mechanotransduction, nitric oxide and vascular inflammation.

Authors:  D G Harrison; J Widder; I Grumbach; W Chen; M Weber; C Searles
Journal:  J Intern Med       Date:  2006-04       Impact factor: 8.989

5.  Reducing the risk of dementia: efficacy of long-term treatment of hypertension.

Authors:  Rita Peila; Lon R White; Kamal Masaki; Helen Petrovitch; Lenore J Launer
Journal:  Stroke       Date:  2006-04-06       Impact factor: 7.914

6.  Reduced cerebral blood flow response and compensation among patients with untreated hypertension.

Authors:  J R Jennings; M F Muldoon; C Ryan; J C Price; P Greer; K Sutton-Tyrrell; F M van der Veen; C C Meltzer
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

7.  Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis.

Authors:  M O'Sullivan; D J Lythgoe; A C Pereira; P E Summers; J M Jarosz; S C R Williams; H S Markus
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

Review 8.  Transient receptor potential (TRP) channels, vascular tone and autoregulation of cerebral blood flow.

Authors:  Joseph E Brayden; Scott Earley; Mark T Nelson; Stacey Reading
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-01-21       Impact factor: 2.557

Review 9.  Prevention of stroke in patients with hypertension.

Authors:  Björn Dahlöf
Journal:  Am J Cardiol       Date:  2007-05-25       Impact factor: 2.778

10.  Endothelium-dependent responses of cerebral blood vessels during chronic hypertension.

Authors:  S T Yang; W G Mayhan; F M Faraci; D D Heistad
Journal:  Hypertension       Date:  1991-05       Impact factor: 10.190

View more
  189 in total

1.  AVR/NAVR deficiency lowers blood pressure and differentially affects urinary concentrating ability, cognition, and anxiety-like behavior in male and female mice.

Authors:  Victoria L M Herrera; Pia Bagamasbad; Julius L Decano; Nelson Ruiz-Opazo
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

Review 2.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

3.  Renal actions of RGS2 control blood pressure.

Authors:  Susan B Gurley; Robert C Griffiths; Michael E Mendelsohn; Richard H Karas; Thomas M Coffman
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

Review 4.  The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.

Authors:  Costantino Iadecola
Journal:  Acta Neuropathol       Date:  2010-07-11       Impact factor: 17.088

5.  Arterial spin labeling measurements of cerebral perfusion territories in experimental ischemic stroke.

Authors:  Renata F Leoni; Fernando F Paiva; Byeong-Teck Kang; Erica C Henning; George C Nascimento; Alberto Tannús; Dráulio B De Araújo; Afonso C Silva
Journal:  Transl Stroke Res       Date:  2011-11-16       Impact factor: 6.829

Review 6.  Smooth muscle cell phenotypic switching in stroke.

Authors:  Marine Poittevin; Pierre Lozeron; Rose Hilal; Bernard I Levy; Tatiana Merkulova-Rainon; Nathalie Kubis
Journal:  Transl Stroke Res       Date:  2013-11-22       Impact factor: 6.829

7.  Neurovascular regulation in the ischemic brain.

Authors:  Katherine Jackman; Costantino Iadecola
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

8.  Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.

Authors:  Thomas Simon O'Hagan; Whitney Wharton; Patrick Gavin Kehoe
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 9.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

10.  Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor.

Authors:  Paulo W Pires; William F Jackson; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.